Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center

Article (Web of Science)

• cited authors: Diaz, Juan Fiorda; Echeverria-Villalobos, Marco; Gutierrez, Alan Esparza; Dada, Olufunke; Stoicea, Nicoleta; Ackermann, Wiebke; Abdel-Rasoul, Mahmoud; Heard, Jarrett; Uribe, Alberto; Bergese, Sergio D. D.
• publication date: December 8, 2022
• webpage: Web of Science
• published in: FRONTIERS IN MEDICINE Journal
• category: MEDICINE, GENERAL & INTERNAL Category

keywords

• cost-benefit analysis
• neostigmine
• neuromuscular blockade
• neuromuscular blocking agents
• rocuronium
• sugammadex

• volume: 9